nodal metastatic disease has a significant effect on prognosis and management. 1 2 Metastases Background -A study was undertaken to investigate the accuracy of positron emis-to contralateral mediastinal lymph nodes (N3 disease) indicates unresectable disease.
pathological examination. Tumour cell type formed blinded and independently by two board-certified nuclear medicine physicians exand stage of disease were classified according to internationally adopted criteria. 25 26 Surgical perienced in PET imaging. treatment (lobectomy or pneumonectomy) was performed for curative reasons in those with UICC stages I-IIIa disease or for various pal-   liative reasons (bronchial bleeding, destroyed The results of chest CT and FDG-PET scans lung, etc) in those with UICC stage IIIb dis-were compared with the histological findings ease. In any case, thorough dissection of me-in the resected lymph nodes to determine diastinal nodes at surgery as a prerequisite for their diagnostic specificity (TN/(TN+FP)), accurate lymph node staging was a consistent sensitivity (TP/(TP+FN)), and accuracy part of all resection strategies. Mediastinal ((TP+TN)/(TP+TN+FP+FN)) in the N lymph node staging was performed according staging of NSCLC (TN=true negative, TP= to the mapping system devised by Naruke et true positive, FP=false positive, FN=false al. 27 Three patients were staged T1, 12 T2, 10 negative). Proportions were furnished with T3, and seven T4. There were 12 patients with their 95% confidence interval. The relative ac-N0 disease, five with N1, 11 with N2, and four curacy of PET imaging compared with CT with N3 disease. The presence of a benign scanning was compared by the McNemar test. finding was proved intraoperatively by histopathological examination of the completely resected lesion at thoracotomy.
Results
The results of histological analysis of thoracic lymph nodes were available from all of the 32     patients with NSCLC (table 1) . FDG-PET During the two weeks before FDG-PET im-was 87.5% accurate for the diagnosis of the aging contrast-enhanced chest CT scanning presence or absence and involved station of was performed with a Pace-scanner (GE Med-thoracic nodal disease whereas CT scanning ical Systems, Milwaukee, Wisconsin, USA) was 59.4% accurate (p<0.02). Two patients from the supraclavicular region to the adrenal with N1 disease were classified as N0 and two glands as described previously.
28 Each CT scan with N2a disease were classified as N1 by was evaluated by two experienced radiologists PET imaging. Three patients with NSCLC blinded to the clinical and PET findings. Me-had enlarged lymph nodes on the CT scan, diastinal lymph nodes were considered diseased suggesting N2 disease, which were negative at if they exceeded 10 mm in the short axis dia-PET imaging (table 2). All nodes were histometer.
logically negative for tumour involvement but had characteristic signs of non-specific inflammation. Four patients with N2 disease had    increased FDG uptake in normal sized nodes PET was performed with a Siemens-CTI-at CT scanning; all had tumour involvement ECAT 931 Scanner (Knoxville, Tennessee, at pathological examination. With regard to USA) using attenuation correction and iterative definitive surgical treatment, FDG-PET could image reconstruction as described previously. 29 reliably identify patients with unresectable N3 Static emission scans from the supraclavicular disease while CT scanning failed in two out of region to the adrenal glands were obtained 50 four. minutes after administration of 18 F-FDG at a In two patients with benign lung processes mean dose of 250 MBq (range 175-350 MBq). (aspergilloma, tuberculosis) there were positive Qualitative evaluation of PET scans was per-ipsilateral hilar lymph nodes at FDG-PET imaging which were enlarged on the CT scan and had histopathologically characteristic signs 1 cm intrapulmonary metastasis of an adeno- * Two patients with N2a nodes were classified as N1 with PET; one patient with N2 disease was classified as N1 with CT.
carcinoma showing no increased FDG uptake group.bmj.com on October 20, 2017 -Published by http://thorax.bmj.com/ Downloaded from vasive method for evaluating regional lymph nodes in patients with NSCLC. 3 4 Regional lymph nodes are considered abnormal by CT scanning if they are more than 1 cm in short axis diameter. 6 7 However, enlarged lymph nodes may be merely hyperplastic and normal sized ones may contain tumour. According to recent studies, malignant mediastinal lymph nodes are not larger than benign nodes and small mediastinal lymph nodes are not infrequently malignant.
31 32 Consequently, the sensitivity and specificity of CT scanning for detecting metastases to mediastinal lymph nodes from NSCLC is as low as 52% and 69%, respectively. 5 Unlike CT scanning and MRI which provide anatomical information and may be valuable for the preoperative assessment of mediastinal or chest wall invasion of lung cancer, 3 4 FDG-PET imaging provides information on in- metabolically highly active tumour in otherwise clinically normal lymph nodes 24 may partly explain why FDG-PET imaging is more accurate than CT scanning for staging regional lymph nodes in patients with NSCLC. Equally interesting was the observation that, in three histologically confirmed cases, enlarged N2 nodes seen on the CT scan showed no FDG uptake and were not involved with tumour (table 2) . Thus, FDG-PET imaging correctly predicted the absence of tumour involvement, while CT scanning falsely suggested the presence of tumour. Our initial data suggest that FDG-PET may supplant invasive diagnostic procedures such as mediastinoscopy in these patients.
Wahl et al 22 reported that FDG-PET alone scanning alone was 65% sensitive and 44% specific. Additionally, in two recently published studies FDG-PET imaging has been shown to and a bronchioloalveolar carcinoma which was considered benign due to less intense, diffuse, be superior to CT scanning in the detection of thoracic lymph node metastases of NSCLC and heterogeneous FDG uptake. The false positive lesions were an aspergilloma with active with accuracies of 100% 35 and 82% 36 compared with 69% for CT scanning; however, they failed inflammation and a florid abscess.
Representative PET images are shown in figs to differentiate various nodal stations 35 and N2/ N3 disease. 36 These studies are therefore of 1 and 2. Figure 1 shows intense FDG uptake in the primary tumour. Additionally, an ipsilateral limited clinical value for distinguishing between patients who are potentially suitable for surgical peribronchial lymph node metastasis is clearly visualised. The corresponding CT scan showed resection and those with unresectable N3 disease. The most important finding of our study no enlarged lymph nodes. In fig 2 a normal sized lymph node seen contralateral to the was that FDG-PET could differentiate reliably between patients with N1/N2 disease and those primary lung tumour on the CT scan shows increased FDG uptake indicating N3 disease with unresectable N3 disease. Thoracotomy for curative resection would have been avoided which was confirmed pathologically.
in two of our patients with N3 disease and normal sized contralateral lymph nodes on the CT scan. In a recent report, using decision tree Discussion Accurate staging of locoregional lymph nodes analysis, the cost effectiveness of FDG-PET in the staging of NSCLC has been shown. 37 in patients with known or suspected NSCLC is necessary, not only to determine the presence Two false negative findings in N1 disease do not devalue FDG-PET imaging since the of N3 disease and unresectability, but also to assist in the selection of those patients with N2 specific level of N1 nodes does not influence surgical treatment and does not appear to have disease who may be candidates for adjuvant or neoadjuvant treatment protocols.
30 CT scan-any prognostic implications. 1 Furthermore, a more reliable although clinically less significant ning is currently the most accepted non-in- arise with FDG-PET imaging of lung tumours 
